Skip to main content
Top
Published in: Pituitary 4/2016

01-08-2016

General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers

Authors: Ozlem Haliloglu, Burak Dogangun, Bahar Ozcabi, Hanife Ugur Kural, Fatma Ela Keskin, Hande Mefkure Ozkaya, Fatma Colkesen Pamukcu, Elif Bektas, Burc Cagri Poyraz, Hakan Buber, Olcay Evliyaoglu, Pinar Kadioglu

Published in: Pituitary | Issue 4/2016

Login to get access

Abstract

Purpose

To determine the physical status and intelligence scores of children of acromegalic mothers and to compare them with those of children from mothers without acromegaly.

Methods

Six women with acromegaly who became pregnant under follow-up between 2010 and 2014 and their 16 children (group A) were assessed and compared with 16 children of healthy women (group B) and 15 children of women with prolactinoma (group C). The physical examinations of children were performed by the department of pediatric endocrinology and intelligence quotient (IQ) testing was undertaken by adult and pediatric psychiatry departments, using appropriate scales for their ages.

Results

Six of the 16 children (girls/boys: 7/9) were born after the diagnosis of acromegaly. Five of the 6 pregnancies occured when the patients were taking somatostatin analogs, none continued taking the drugs during pregnancy. The mean IQ of groups A, B, and C were 106.4 ± 12.5, 105.3 ± 12.5, and 103.2 ± 16.1 respectively (p > 0.05). The mean ages, birth percentiles, recent weight and height standard deviation scores were similar between groups (p > 0.05). Two siblings from group A and 1 child from group B were large for gestational age at birth. At recent follow-up, two children from group A were found tall for their age and one from group C was short for his age and was placed under the care of pediatric endocrinology clinic.

Conclusions

Pregnancies in acromegaly seems to be uneventful and the general health status and IQ scores of children from women with and without acromegaly were found similar.
Literature
1.
go back to reference Hsu CJ, Hammond JM (1987) Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121(4):1343–1348CrossRefPubMed Hsu CJ, Hammond JM (1987) Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121(4):1343–1348CrossRefPubMed
2.
go back to reference Kaltsas GA, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G (2007) Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol (Oxf) 67(6):917–922CrossRef Kaltsas GA, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G (2007) Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol (Oxf) 67(6):917–922CrossRef
3.
go back to reference Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680–4687CrossRefPubMed Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680–4687CrossRefPubMed
4.
go back to reference Caron P (2011) Acromegaly and pregnancy. Ann Endocrinol (Paris) 72(4):282–286CrossRef Caron P (2011) Acromegaly and pregnancy. Ann Endocrinol (Paris) 72(4):282–286CrossRef
5.
go back to reference Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518–4525CrossRefPubMed Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518–4525CrossRefPubMed
6.
go back to reference Kaltsas GA, Mukherjee JJ, Jenkins PJ, Satta MA, Islam N, Monson JP, Besser GM, Grossman AB (1999) Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab 84(8):2731–2735CrossRefPubMed Kaltsas GA, Mukherjee JJ, Jenkins PJ, Satta MA, Islam N, Monson JP, Besser GM, Grossman AB (1999) Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab 84(8):2731–2735CrossRefPubMed
7.
go back to reference Karaca Z, Kelestimur F (2011) Pregnancy and other pituitary disorders (including GH deficiency). Best Pract Res Clin Endocrinol Metab 25(6):897–910CrossRefPubMed Karaca Z, Kelestimur F (2011) Pregnancy and other pituitary disorders (including GH deficiency). Best Pract Res Clin Endocrinol Metab 25(6):897–910CrossRefPubMed
8.
go back to reference Okada Y, Morimoto I, Ejima K, Yoshida K, Kashimura M, Fujihira T, Eto S (1997) A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocr J 44(1):117–120CrossRefPubMed Okada Y, Morimoto I, Ejima K, Yoshida K, Kashimura M, Fujihira T, Eto S (1997) A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocr J 44(1):117–120CrossRefPubMed
9.
go back to reference Jaspers C, Haase R, Pfingsten H, Benker G, Reinwein D (1993) Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine. Clin Investig 71(7):547–551CrossRefPubMed Jaspers C, Haase R, Pfingsten H, Benker G, Reinwein D (1993) Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine. Clin Investig 71(7):547–551CrossRefPubMed
10.
go back to reference Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B (2001) Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol (Oxf) 55(3):411–415CrossRef Fassnacht M, Capeller B, Arlt W, Steck T, Allolio B (2001) Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol (Oxf) 55(3):411–415CrossRef
11.
go back to reference Takano T, Saito J, Soyama A, Ito H, Iizuka T, Yoshida T, Nishikawa T (2006) Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy. Endocr J 53(2):209–212CrossRefPubMed Takano T, Saito J, Soyama A, Ito H, Iizuka T, Yoshida T, Nishikawa T (2006) Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy. Endocr J 53(2):209–212CrossRefPubMed
12.
go back to reference Maffei P, Tamagno G, Nardelli GB, Videau C, Menegazzo C, Milan G, Calcagno A, Martini C, Vettor R, Epelbaum J, Sicolo N (2010) Effects of octreotide exposure during pregnancy in acromegaly. Clin Endocrinol (Oxf) 72(5):668–677CrossRef Maffei P, Tamagno G, Nardelli GB, Videau C, Menegazzo C, Milan G, Calcagno A, Martini C, Vettor R, Epelbaum J, Sicolo N (2010) Effects of octreotide exposure during pregnancy in acromegaly. Clin Endocrinol (Oxf) 72(5):668–677CrossRef
13.
go back to reference Mikhail N (2002) Octreotide treatment of acromegaly during pregnancy. Mayo Clin Proc 77(3):297–298CrossRefPubMed Mikhail N (2002) Octreotide treatment of acromegaly during pregnancy. Mayo Clin Proc 77(3):297–298CrossRefPubMed
14.
go back to reference Neal JM (2000) Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr Pract 6(2):148–150CrossRefPubMed Neal JM (2000) Successful pregnancy in a woman with acromegaly treated with octreotide. Endocr Pract 6(2):148–150CrossRefPubMed
15.
go back to reference Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A (2012) Pregnancy and acromegaly: a review. Pituitary 15(1):59–63CrossRefPubMed Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A (2012) Pregnancy and acromegaly: a review. Pituitary 15(1):59–63CrossRefPubMed
16.
go back to reference Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693–721CrossRefPubMed Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693–721CrossRefPubMed
17.
go back to reference Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ (1988) Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85(2):217–220CrossRefPubMed Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ (1988) Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85(2):217–220CrossRefPubMed
18.
go back to reference Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F (2009) Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm IGF Res 19(1):24–30CrossRefPubMed Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F (2009) Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm IGF Res 19(1):24–30CrossRefPubMed
19.
go back to reference Sievers C, Samann PG, Dose T, Dimopoulou C, Spieler D, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Czisch M, Pfister H, Stalla GK (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 12(3):177–185CrossRefPubMed Sievers C, Samann PG, Dose T, Dimopoulou C, Spieler D, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Czisch M, Pfister H, Stalla GK (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 12(3):177–185CrossRefPubMed
20.
go back to reference Crespo I, Santos A, Valassi E, Pires P, Webb SM, Resmini E (2015) Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly. Endocrine 50(3):756–763CrossRefPubMed Crespo I, Santos A, Valassi E, Pires P, Webb SM, Resmini E (2015) Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly. Endocrine 50(3):756–763CrossRefPubMed
21.
go back to reference Yedinak CG, Fleseriu M (2014) Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine 46(3):585–593CrossRefPubMed Yedinak CG, Fleseriu M (2014) Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine 46(3):585–593CrossRefPubMed
22.
go back to reference Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-Lopez P, Galvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95(9):4367–4379CrossRefPubMed Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-Lopez P, Galvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95(9):4367–4379CrossRefPubMed
23.
go back to reference Kayaalp LAF, Alsancak B, Duzen E, Dogangun B (2010) The norms, reliability and validity of the Brunet Lezine test in Turkish children. Turk Arch Pediatr 45:86–95CrossRef Kayaalp LAF, Alsancak B, Duzen E, Dogangun B (2010) The norms, reliability and validity of the Brunet Lezine test in Turkish children. Turk Arch Pediatr 45:86–95CrossRef
24.
go back to reference Semin R (1972) Binet-Stanford testlerinin Istanbul cocuklarina standartlanmasi, 2nd edn. Istanbul University Faculty of Science Publishing, Istanbul Semin R (1972) Binet-Stanford testlerinin Istanbul cocuklarina standartlanmasi, 2nd edn. Istanbul University Faculty of Science Publishing, Istanbul
25.
go back to reference Sahin ISN (1995) Wechsler Cocuklar Icin Zeka Olcegi (WISC-R) El Kitabi. Turk Psikologlar Dernegi Publishing, Ankara Sahin ISN (1995) Wechsler Cocuklar Icin Zeka Olcegi (WISC-R) El Kitabi. Turk Psikologlar Dernegi Publishing, Ankara
26.
go back to reference Togrol B (1974) Cattell zeka testinin 2A ve 2B formlari ile Porteus labirenti zeka testinin 1300 Turk cocuguna uygulanmasi. Tec. Psikoloji Calismalari Togrol B (1974) Cattell zeka testinin 2A ve 2B formlari ile Porteus labirenti zeka testinin 1300 Turk cocuguna uygulanmasi. Tec. Psikoloji Calismalari
28.
go back to reference Fleseriu M (2015) Medical treatment of acromegaly in pregnancy, highlights on new reports. Endocrine 49(3):577–579CrossRefPubMed Fleseriu M (2015) Medical treatment of acromegaly in pregnancy, highlights on new reports. Endocrine 49(3):577–579CrossRefPubMed
29.
go back to reference Cheng S, Grasso L, Martinez-Orozco JA, Al-Agha R, Pivonello R, Colao A, Ezzat S (2012) Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf) 76(2):264–271CrossRef Cheng S, Grasso L, Martinez-Orozco JA, Al-Agha R, Pivonello R, Colao A, Ezzat S (2012) Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol (Oxf) 76(2):264–271CrossRef
30.
go back to reference Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 92(9):3374–3377CrossRefPubMed Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 92(9):3374–3377CrossRefPubMed
31.
go back to reference Caron P, Buscail L, Beckers A, Esteve JP, Igout A, Hennen G, Susini C (1997) Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metab 82(11):3771–3776PubMed Caron P, Buscail L, Beckers A, Esteve JP, Igout A, Hennen G, Susini C (1997) Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metab 82(11):3771–3776PubMed
32.
go back to reference van Dam PS, Aleman A (2004) Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol 490(1–3):87–95PubMed van Dam PS, Aleman A (2004) Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol 490(1–3):87–95PubMed
33.
go back to reference Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol (Oxf) 71(5):691–701CrossRef Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol (Oxf) 71(5):691–701CrossRef
34.
go back to reference Richert S, Strauss A, Fahlbusch R, Oeckler R, von Werder K (1987) Psychopathologic symptoms and personality traits in patients with florid acromegaly. Schweiz Arch Neurol Psychiatr 138(3):61–86PubMed Richert S, Strauss A, Fahlbusch R, Oeckler R, von Werder K (1987) Psychopathologic symptoms and personality traits in patients with florid acromegaly. Schweiz Arch Neurol Psychiatr 138(3):61–86PubMed
35.
go back to reference Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab 95(12):E392–E402CrossRefPubMed Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab 95(12):E392–E402CrossRefPubMed
36.
go back to reference Brummelman P, Koerts J, Dullaart RP, van den Berg G, Tucha O, Wolffenbuttel BH, van Beek AP (2012) Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur J Clin Invest 42(12):1317–1324CrossRefPubMed Brummelman P, Koerts J, Dullaart RP, van den Berg G, Tucha O, Wolffenbuttel BH, van Beek AP (2012) Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition. Eur J Clin Invest 42(12):1317–1324CrossRefPubMed
37.
go back to reference Levy-Shraga Y, Pinhas-Hamiel O, Kraus-Houminer E, Landau H, Mazor-Aronovitch K, Modan-Moses D, Gillis D, Koren I, Dollberg D, Gabis LV (2013) Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism. J Pediatr Endocrinol Metab 26(3–4):301–308PubMed Levy-Shraga Y, Pinhas-Hamiel O, Kraus-Houminer E, Landau H, Mazor-Aronovitch K, Modan-Moses D, Gillis D, Koren I, Dollberg D, Gabis LV (2013) Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism. J Pediatr Endocrinol Metab 26(3–4):301–308PubMed
38.
go back to reference Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB (2007) Two years of growth hormone therapy in young children with Prader–Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143A(5):443–448CrossRefPubMed Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB (2007) Two years of growth hormone therapy in young children with Prader–Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143A(5):443–448CrossRefPubMed
39.
go back to reference Postma MR, Netea-Maier RT, van den Berg G, Homan J, Sluiter WJ, Wagenmakers MA, van den Bergh AC, Wolffenbuttel BH, Hermus AR, van Beek AP (2012) Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur J Endocrinol 166(4):585–592CrossRefPubMed Postma MR, Netea-Maier RT, van den Berg G, Homan J, Sluiter WJ, Wagenmakers MA, van den Bergh AC, Wolffenbuttel BH, Hermus AR, van Beek AP (2012) Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur J Endocrinol 166(4):585–592CrossRefPubMed
40.
go back to reference Ruchala M, Stangierska I, Gurgul E, Stangierski A, Fajfer J, Sowinski J (2010) The effect of octreotide treatment on somatic and psychological symptoms of acromegaly. Neuroendocrinol Lett 31(2):265–269PubMed Ruchala M, Stangierska I, Gurgul E, Stangierski A, Fajfer J, Sowinski J (2010) The effect of octreotide treatment on somatic and psychological symptoms of acromegaly. Neuroendocrinol Lett 31(2):265–269PubMed
41.
go back to reference Sonino N, Scarpa E, Paoletta A, Fallo F, Boscaro M (1999) Slow-release lanreotide treatment in acromegaly: effects on quality of life. Psychother Psychosom 68(3):165–167CrossRefPubMed Sonino N, Scarpa E, Paoletta A, Fallo F, Boscaro M (1999) Slow-release lanreotide treatment in acromegaly: effects on quality of life. Psychother Psychosom 68(3):165–167CrossRefPubMed
42.
go back to reference Wiesli P, Zwimpfer C, Zapf J, Schmid C (2006) Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta Obstet Gynecol Scand 85(8):900–905CrossRefPubMed Wiesli P, Zwimpfer C, Zapf J, Schmid C (2006) Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta Obstet Gynecol Scand 85(8):900–905CrossRefPubMed
43.
go back to reference Beckers A, Stevenaert A, Foidart JM, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71(3):725–731CrossRefPubMed Beckers A, Stevenaert A, Foidart JM, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71(3):725–731CrossRefPubMed
44.
go back to reference Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155(2):279–284CrossRefPubMed Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155(2):279–284CrossRefPubMed
45.
go back to reference Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301–310CrossRefPubMed Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301–310CrossRefPubMed
46.
go back to reference Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114(3):135–139CrossRefPubMed Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114(3):135–139CrossRefPubMed
47.
go back to reference van der Lely AJ, Gomez R, Heissler JF, Akerblad AC, Jonsson P, Camacho-Hubner C, Koltowska-Haggstrom M (2014) Pregnancy in acromegaly patients treated with pegvisomant. Endocrine 49(3):769–773CrossRefPubMed van der Lely AJ, Gomez R, Heissler JF, Akerblad AC, Jonsson P, Camacho-Hubner C, Koltowska-Haggstrom M (2014) Pregnancy in acromegaly patients treated with pegvisomant. Endocrine 49(3):769–773CrossRefPubMed
48.
go back to reference Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82(9):2777–2781CrossRefPubMed Colao A, Merola B, Ferone D, Lombardi G (1997) Acromegaly. J Clin Endocrinol Metab 82(9):2777–2781CrossRefPubMed
49.
go back to reference Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83(3):727–731PubMed Herman-Bonert V, Seliverstov M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83(3):727–731PubMed
Metadata
Title
General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers
Authors
Ozlem Haliloglu
Burak Dogangun
Bahar Ozcabi
Hanife Ugur Kural
Fatma Ela Keskin
Hande Mefkure Ozkaya
Fatma Colkesen Pamukcu
Elif Bektas
Burc Cagri Poyraz
Hakan Buber
Olcay Evliyaoglu
Pinar Kadioglu
Publication date
01-08-2016
Publisher
Springer US
Published in
Pituitary / Issue 4/2016
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-016-0717-2

Other articles of this Issue 4/2016

Pituitary 4/2016 Go to the issue